Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
PPL Corp
PPL
$26.9B
| $483M | 0.1% |
14,671,257
-67,203
| -0.5% | -$2.34M |
2013 Q2
53 quarters
|
|
127
Astera Labs
ALAB
$37.8B
| $480M | 0.1% |
1,349,025
+218,081
| +19% | +$70.2M |
2024 Q1
10 quarters
|
|
128
PUT
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.96B
| $480M | 0.1% |
2,674,400
+2,524,400
| +1,683% | +$450M |
2024 Q3
8 quarters
|
|
129
CALL
SpaceX
SPCX
$1.94T
| $478M | 0.1% |
3,169,700
+3,034,900
| +2,251% | +$420M |
2026 Q2
1 quarter
|
|
130
Microchip Technology
MCHP
$32.8B
| $478M | 0.1% |
6,144,378
-880,018
| -13% | -$68.6M |
2013 Q2
53 quarters
|
|
131
Boston Scientific
BSX
$64.8B
| $475M | 0.1% |
10,883,044
+6,298,784
| +137% | +$292M |
2013 Q2
53 quarters
|
|
132
Gilead Sciences
GILD
$212B
| $468M | 0.09% |
3,141,208
-1,972,034
| -39% | -$277M |
2013 Q2
53 quarters
|
|
133
State Street SPDR S&P Biotech ETF
XBI
$10.5B
| $467M | 0.09% |
2,959,750
+141,807
| +5% | +$22.4M |
2013 Q2
53 quarters
|
|
134
Adobe
ADBE
$92.1B
| $464M | 0.09% |
1,933,844
+110,278
| +6% | +$27.6M |
2013 Q2
53 quarters
|
|
135
Millicom
TIGO
$14.9B
| $454M | 0.09% |
5,210,952
+2,538,612
| +95% | +$240M |
2024 Q2
9 quarters
|
|
136
HCA Healthcare
HCA
$105B
| $453M | 0.09% |
1,061,944
-257,272
| -20% | -$105M |
2013 Q2
53 quarters
|
|
|
137
CALL
Tesla
TSLA
$1.5T
| $443M | 0.09% |
1,249,900
+213,100
| +21% | +$76.3M |
2023 Q4
11 quarters
|
|
138
PUT
State Street Financial Select Sector SPDR ETF
XLF
$55.2B
| $442M | 0.09% |
8,269,000
+369,000
| +5% | +$20.9M |
2024 Q3
8 quarters
|
|
139
Dell
DELL
$213B
| $439M | 0.09% |
815,259
-474,894
| -37% | -$223M |
2016 Q3
40 quarters
|
|
140
GE Aerospace
GE
$351B
| $437M | 0.09% |
1,400,191
-728,884
| -34% | -$253M |
2022 Q1
18 quarters
|
|
141
Parker-Hannifin
PH
$122B
| $435M | 0.09% |
455,562
-13,447
| -3% | -$13.2M |
2013 Q2
53 quarters
|
|
142
Coca-Cola
KO
$417B
| $427M | 0.09% |
4,965,472
-2,125,384
| -30% | -$184M |
2013 Q2
53 quarters
|
|
143
PUT
TSMC
TSM
$2.06T
| $426M | 0.09% |
934,800
+590,700
| +172% | +$250M |
2024 Q3
8 quarters
|
|
144
Pfizer
PFE
$167B
| $426M | 0.09% |
14,932,574
-1,814,227
| -11% | -$48.3M |
2013 Q2
53 quarters
|
|
145
PUT
iShares MSCI EAFE ETF
EFA
$77.5B
| $423M | 0.08% |
4,076,094
+1,596,500
| +64% | +$169M |
2023 Q4
11 quarters
|
|
146
State Street Consumer Staples Select Sector SPDR ETF
XLP
$15.1B
| $417M | 0.08% |
5,167,798
-1,313,583
| -20% | -$111M |
2013 Q2
53 quarters
|
|
147
SPDR Gold Trust
GLD
$135B
| $410M | 0.08% |
1,075,543
-463,824
| -30% | -$181M |
2013 Q2
53 quarters
|
|
148
CALL
iShares Bitcoin Trust
IBIT
$59.1B
| $401M | 0.08% |
8,479,800
+5,198,300
| +158% | +$210M |
2025 Q2
5 quarters
|
|
149
PUT
Moderna
MRNA
$101B
| $400M | 0.08% |
2,075,900
+1,453,200
| +233% | +$157M |
2025 Q1
6 quarters
|
|
150
McKesson
MCK
$125B
| $397M | 0.08% |
464,622
+77,432
| +20% | +$66.6M |
2013 Q2
53 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.